Clinical Trial

A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 7, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This will be an open-label, randomized, single-site, 8-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters and overall product liking (OPL) following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy adult combustible cigarette smokers and smokers who also use ENDS products.
Trial Details
NCT Number NCT07323563
Lead Sponsor RAI Services Company
Conditions Smoking, Smoking Behaviors, Tobacco Use, Tobacco Smoking
Enrollment 40 participants
Start Date 2026-03-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-07